IMP Intrinsic Valuation and Fundamental Analysis - Imexpharm Corp - Alpha Spread
I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 49 900 VND -1.58% Market Closed
Market Cap: 3.8T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Intrinsic Value

The intrinsic value of one IMP stock under the Base Case scenario is 43 776.37 VND. Compared to the current market price of 49 900 VND, Imexpharm Corp is Overvalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IMP Intrinsic Value
43 776.37 VND
Overvaluation 12%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation Backtest
Imexpharm Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IMP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IMP?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Imexpharm Corp

Provide an overview of the primary business activities
of Imexpharm Corp.

What unique competitive advantages
does Imexpharm Corp hold over its rivals?

What risks and challenges
does Imexpharm Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Imexpharm Corp.

Provide P/S
for Imexpharm Corp.

Provide P/E
for Imexpharm Corp.

Provide P/OCF
for Imexpharm Corp.

Provide P/FCFE
for Imexpharm Corp.

Provide P/B
for Imexpharm Corp.

Provide EV/S
for Imexpharm Corp.

Provide EV/GP
for Imexpharm Corp.

Provide EV/EBITDA
for Imexpharm Corp.

Provide EV/EBIT
for Imexpharm Corp.

Provide EV/OCF
for Imexpharm Corp.

Provide EV/FCFF
for Imexpharm Corp.

Provide EV/IC
for Imexpharm Corp.

Show me price targets
for Imexpharm Corp made by professional analysts.

What are the Revenue projections
for Imexpharm Corp?

How accurate were the past Revenue estimates
for Imexpharm Corp?

What are the Net Income projections
for Imexpharm Corp?

How accurate were the past Net Income estimates
for Imexpharm Corp?

What are the EPS projections
for Imexpharm Corp?

How accurate were the past EPS estimates
for Imexpharm Corp?

What are the EBIT projections
for Imexpharm Corp?

How accurate were the past EBIT estimates
for Imexpharm Corp?

Compare the revenue forecasts
for Imexpharm Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Imexpharm Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Imexpharm Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Imexpharm Corp compared to its peers.

Compare the P/E ratios
of Imexpharm Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Imexpharm Corp with its peers.

Analyze the financial leverage
of Imexpharm Corp compared to its main competitors.

Show all profitability ratios
for Imexpharm Corp.

Provide ROE
for Imexpharm Corp.

Provide ROA
for Imexpharm Corp.

Provide ROIC
for Imexpharm Corp.

Provide ROCE
for Imexpharm Corp.

Provide Gross Margin
for Imexpharm Corp.

Provide Operating Margin
for Imexpharm Corp.

Provide Net Margin
for Imexpharm Corp.

Provide FCF Margin
for Imexpharm Corp.

Show all solvency ratios
for Imexpharm Corp.

Provide D/E Ratio
for Imexpharm Corp.

Provide D/A Ratio
for Imexpharm Corp.

Provide Interest Coverage Ratio
for Imexpharm Corp.

Provide Altman Z-Score Ratio
for Imexpharm Corp.

Provide Quick Ratio
for Imexpharm Corp.

Provide Current Ratio
for Imexpharm Corp.

Provide Cash Ratio
for Imexpharm Corp.

What is the historical Revenue growth
over the last 5 years for Imexpharm Corp?

What is the historical Net Income growth
over the last 5 years for Imexpharm Corp?

What is the current Free Cash Flow
of Imexpharm Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Imexpharm Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Imexpharm Corp

Current Assets 1.4T
Cash & Short-Term Investments 259.5B
Receivables 353.2B
Other Current Assets 746.6B
Non-Current Assets 1.1T
Long-Term Investments 71.3B
PP&E 878.1B
Intangibles 75.1B
Other Non-Current Assets 121.3B
Current Liabilities 427.3B
Accounts Payable 71.8B
Accrued Liabilities 98.9B
Short-Term Debt 96.4B
Other Current Liabilities 160.2B
Efficiency

Earnings Waterfall
Imexpharm Corp

Revenue
2.1T VND
Cost of Revenue
-1.3T VND
Gross Profit
767.6B VND
Operating Expenses
-437.7B VND
Operating Income
329.9B VND
Other Expenses
-90.6B VND
Net Income
239.3B VND

Free Cash Flow Analysis
Imexpharm Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IMP Profitability Score
Profitability Due Diligence

Imexpharm Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Operating Income
57/100
Profitability
Score

Imexpharm Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

IMP Solvency Score
Solvency Due Diligence

Imexpharm Corp's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Low D/E
95/100
Solvency
Score

Imexpharm Corp's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMP Price Targets Summary
Imexpharm Corp

Wall Street analysts forecast IMP stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMP is 42 308.36 VND with a low forecast of 33 972.73 VND and a high forecast of 48 300 VND.

Lowest
Price Target
33 972.73 VND
32% Downside
Average
Price Target
42 308.36 VND
15% Downside
Highest
Price Target
48 300 VND
3% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IMP?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Oct 7, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Want to learn more about IMP dividends?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for IMP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Imexpharm Corp

Country

Vietnam

Industry

Pharmaceuticals

Market Cap

3.8T VND

Dividend Yield

1.91%

Description

Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

Contact

DONG THAP
Cao Lanh
So 04, Duong 30/04, Phuong 1
+842773851941
www.imexpharm.com

IPO

2006-12-04

Employees

1 356

Officers

See Also

Discover More
What is the Intrinsic Value of one IMP stock?

The intrinsic value of one IMP stock under the Base Case scenario is 43 776.37 VND.

Is IMP stock undervalued or overvalued?

Compared to the current market price of 49 900 VND, Imexpharm Corp is Overvalued by 12%.

Back to Top